Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 60505-3659

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 60505-3659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sime_btl_lbl_50_1000mg (Sime Btl Lbl 50 1000mg)

This text provides information about a medication that combines sitagliptin phosphate and metformin hydrochloride. Each film-coated tablet contains 50 mg of sitagliptin and 1000 mg of metformin. The medication is manufactured for a specific purpose and should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). The usual dosage and precautions for dispensing are mentioned as well.*

FDA Label Image

Sime_btl_lbl_50_500mg (Sime Btl Lbl 50 500mg)

Each film-coated tablet contains 64.25 mg of sitagliptin phosphate (equivalent to 50 mg sitagliptin) and 500 mg of metformin hydrochloride. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions allowed to 15°C to 30°C (59°F to 86°F). Dispense in a tight container as per USP guidelines. The usual dosage information can be found in the Package Insert. This medication, containing both Sitagliptin and Metformin Hydrochloride, is available in a 50 mg/500 mg strength. It is recommended to dispense with a Medication Guide and is produced by Apotex Corp. in Ontario, Canada, for distribution by Apotex Corp. in Weston, Florida.*

FDA Label Image

Sitagliptinmetformin-01 (Sitagliptinmetformin 01)

FDA Label Image

Sitagliptinmetformin-02 (Sitagliptinmetformin 02)

FDA Label Image

Sitagliptinmetformin-03 (Sitagliptinmetformin 03)

This text evaluates different treatment regimens involving placebo, metformin, and sitagliptin for managing hyperglycemia. The treatment options include metformin alone in different doses, sitagliptin alone, and combinations of sitagliptin with metformin. The data presented is for the "All Patients Treated Population," with the results adjusted for prior antihyperglycemic therapy and baseline values.*

FDA Label Image

Sitagliptinmetformin-04 (Sitagliptinmetformin 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.